Tech Company Financing Transactions
Mersana Therapeutics Funding Round
Mersana Therapeutics, based in Cambridge, secured $35 million from New Enterprise Associates, F-Prime Capital and private investors.
Transaction Overview
New Enterprise Associates (Lead Investor) (David Mott)
F-Prime Capital (Thomas Beck)
private investors (Elliott Sigal)
Company Information
Cambridge, MA 02139
USA
Management Team
Browse more venture capital transactions:
Prev: 3/2/2015: Workable venture capital transaction
Next: 3/2/2015: Solicore venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs